Dr. Garabet Yeretssian is the Program Director for the Helmsley Charitable Trust’s IBD and Crohn’s Disease Program, which aspires to improve the quality of life for patients and find better therapeutic and prevention strategies for these debilitating diseases.
Prior to joining Helmsley, Garabet was an assistant professor in the Immunology Institute at the Icahn School of Medicine at Mount Sinai where he led a research team investigating the implication of innate immune mechanisms in IBD, Crohn’s disease, colorectal cancer, and other gastrointestinal disorders. Previously, he was a postdoctoral fellow and later on an associate researcher at McGill University, studying host-microbe interactions at mucosal surfaces.
Garabet earned a PhD in Biotechnology, Cell and Molecular Biology from the University of Nantes, France, and an MSc degree in Biochemistry, Cell and Molecular Biology from the University of Burgundy. Earlier, he also completed an MSc degree in Biological Sciences at the Lebanese University in Beirut.